Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction
about
Selenium and inflammatory bowel diseaseAltered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiologyTransient receptor potential ankyrin-1 has a major role in mediating visceral pain in mice.A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis.Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury.Activated fluid transport regulates bacterial-epithelial interactions and significantly shifts the murine colonic microbiome.Activation of the prostaglandin D2 metabolic pathway in Crohn's disease: involvement of the enteric nervous systemEmerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense.Molecular mechanisms of disturbed electrolyte transport in intestinal inflammation.Anti-Inflammatory mechanisms of enteric Heligmosomoides polygyrus infection against trinitrobenzene sulfonic acid-induced colitis in a murine model.Decoding epithelial signals: critical role for the epidermal growth factor receptor in controlling intestinal transport function.Alterations to enteric neural signaling underlie secretory abnormalities of the ileum in experimental colitis in the guinea pigMelatonin reduces bacterial translocation and apoptosis in trinitrobenzene sulphonic acid-induced colitis of rats.Molecular bases of impaired water and ion movements in inflammatory bowel diseases.Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis.Systematic review of animal models of post-infectious/post-inflammatory irritable bowel syndrome.Prostanoids receptors signaling in different diseases/cancers progression.Predisposition to colorectal cancer in rats with resolved colitis: role of cyclooxygenase-2-derived prostaglandin d2.Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients.Plasticity of neuroeffector transmission during bowel inflammation1.Flavonoids exert distinct modulatory actions on cyclooxygenase 2 and NF-kappaB in an intestinal epithelial cell line (IEC18).The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis modelCurcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2Effect of E. coli Nissle 1917 on post-inflammatory visceral sensory function in a rat model.Changes in colonic motility and the electrophysiological properties of myenteric neurons persist following recovery from trinitrobenzene sulfonic acid colitis in the guinea pig.Persistent alterations to enteric neural signaling in the guinea pig colon following the resolution of colitis.Alteration of neuromuscular transmissions in the hamster colon following the resolution of TNBS-induced colitis.Epithelial barrier disruption allows nondisease-causing bacteria to initiate and sustain IBD in the IL-10 gene-deficient mouse.[Dual role for prostaglandin D2 in intestinal epithelial homeostasis].Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.Extracellular Vesicles From the Helminth Fasciola hepatica Prevent DSS-Induced Acute Ulcerative Colitis in a T-Lymphocyte Independent Mode.Citrobacter rodentium infection causes iNOS-independent intestinal epithelial dysfunction in miceIL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE
P2860
Q28085300-51597DBD-33B8-4B5C-83C8-CD975C7BDF9FQ28534532-83ABF4F2-8493-4253-932C-965BB7565C47Q33588995-8EB1ADE2-C92A-4350-BED9-6DAC63025C2AQ33977744-6B670C88-AEA8-47F4-8AEC-C39FAE032086Q34226230-13849301-A1A7-496B-98B5-CD72AEA78E05Q34276638-C908A687-9F99-4E8F-BF27-840F8572CF6FQ35764322-AC578DCC-20CD-47C6-8735-780FEB8C05D0Q36075305-558DE344-3B35-4A33-9F2B-3C4306EF2F36Q36631477-143FA856-7177-4CF4-A4CB-BD89804D722DQ36898582-75353B0D-6E88-4A42-91C1-5C3937754454Q37071356-5C8F9E68-CDCB-4EF2-BB44-4E6D28853795Q37162429-A4C1250E-C700-4154-BFB1-64A559F93E9EQ37203835-AE314BB0-4FC6-480E-829D-FE938A5C429AQ37216498-74DE98ED-96DC-41F0-B543-21D4C16940E7Q37665071-63F749B6-EC67-4567-A3D7-63137E09FE49Q37789650-81310E6B-4974-4864-9620-138A20034C19Q38074716-638E2B6F-FDEE-4167-A2C4-CF326E0768B7Q38597613-C491D87C-2323-4878-91AA-AAB434659778Q38831798-9D244654-7089-4388-8867-7C31C6DB0B4AQ39084412-896AB9C5-CC61-42EB-9AF1-AE94E59604EEQ39677386-50CCE38F-422B-4B23-839A-074DF0155447Q42490778-FA64CFF2-486E-49AB-B562-29CC0F061CECQ42726235-71EA5AD6-1AE8-470E-9553-E6EB000B2F53Q46509752-B1BDB8AE-9724-4B30-BD8B-0E07BEA4EDE9Q46921550-A9037703-FBC4-443D-810A-F7BAC925C241Q48659218-28C0F049-F40A-43CB-8D7F-3F4866510B73Q51753894-3BD50FE8-B15E-4BCE-8F39-985F61F57BA2Q52578345-34A0FAE5-F9C8-4F7E-A823-C5DA68491BFAQ53436493-8914BCC8-C290-4C4C-A6A3-16205EFFAF54Q53614343-3A63BCDE-179B-4799-87C9-4ACFCB06AC91Q55340933-735053E8-B9EB-4C31-AC01-A2E7C082095CQ56119301-FF05B669-9AC8-42CF-AA2E-9CC6A800986AQ58770481-2A753D99-2234-4D14-93EB-71D9ADDEBE98
P2860
Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction
@ast
Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction
@en
type
label
Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction
@ast
Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction
@en
prefLabel
Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction
@ast
Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction
@en
P2093
P2860
P356
P1433
P1476
Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction
@en
P2093
J L Wallace
S R Zamuner
W K MacNaughton
P2860
P304
P356
10.1136/GUT.52.12.1714
P407
P577
2003-12-01T00:00:00Z